Novartis AG
Polyomavirus neutralizing antibodies
Last updated:
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Status:
Grant
Type:
Utility
Filling date:
7 Nov 2018
Issue date:
19 May 2020